Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to look at the benefits of tiotropium, an approved drug for the treatment of bronchospasm associated with COPD (chronic obstructive pulmonary disease), in a population of patients with COPD who are of African American descent.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Bromides; Tiotropium Bromide

Criteria

Inclusion Criteria:

• Male or female of African descent

• 40 years of age or older

• Diagnosis of COPD

• History of smoking at least one pack per day for at least 10 years

• Currently experiencing shortness of breath at least with exertion

Exclusion Criteria:

• Asthma

• Recent myocardial infarction or hospitalization for congestive heart failure